Dimensional Fund Advisors LP Albireo Pharma, Inc. Transaction History

Dimensional Fund Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$18.01 - $23.78 $93,561 - $123,537	5,195 Added 1.96%	269,731 $5.83 Million
Q3 2022 Nov 10, 2022	SELL	$16.32 - $26.37 $2.03 Million - $3.28 Million	-124,321 Reduced 31.97%	264,536 $5.12 Million
Q2 2022 Aug 12, 2022	BUY	$18.54 - $37.29 $515,337 - $1.04 Million	27,796 Added 7.7%	388,857 $7.72 Million
Q1 2022 May 13, 2022	BUY	$23.94 - $33.74 $825,594 - $1.16 Million	34,486 Added 10.56%	361,061 $10.8 Million
Q4 2021 Feb 09, 2022	BUY	$21.19 - $31.29 $277,737 - $410,118	13,107 Added 4.18%	326,575 $7.61 Million
Q3 2021 Nov 12, 2021	SELL	$27.36 - $35.98 $1.96 Million - $2.58 Million	-71,626 Reduced 18.6%	313,468 $9.78 Million
Q2 2021 Aug 12, 2021	BUY	$28.9 - $36.87 $926,273 - $1.18 Million	32,051 Added 9.08%	385,094 $13.5 Million
Q1 2021 May 14, 2021	BUY	$32.03 - $42.85 $2.07 Million - $2.77 Million	64,607 Added 22.4%	353,043 $12.4 Million
Q4 2020 Feb 25, 2021	BUY	$31.56 - $42.16 $9.1 Million - $12.2 Million	288,436 New	288,436 $10.8 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.